Baird’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$10.4M Sell
109,694
-3,307
-3% -$306K 0.11% 204
2014
Q4
$10M Sell
113,001
-1,767
-2% -$150K 0.11% 212
2014
Q3
$9.18M Sell
114,768
-1,394
-1% -$105K 0.13% 169
2014
Q2
$8.24M Buy
116,162
+3,932
+4% +$277K 0.12% 183
2014
Q1
$8.31M Buy
112,230
+16,947
+18% +$1.28M 0.12% 185
2013
Q4
$7.48M Buy
95,283
+9,232
+11% +$723K 0.13% 190
2013
Q3
$6.36M Sell
86,051
-15,337
-15% -$1.13M 0.12% 211
2013
Q2
$7.7M Buy
+101,388
New +$6.65M 0.15% 183

Other funds holding CME

Baird's CME Position: Q1 2015 in Review

Baird reduced its CME Group (CME) stake by 2.9% in Q1 2015, selling an estimated $306K and leaving 109,694 shares worth $10.4M. The position accounts for 0.11% of the portfolio, ranked #204.

Baird first reported a position in CME in Q2 2013 and has held it in 8 quarters since. 588 funds tracked by Wall St. Rank hold CME as of Q1 2015.

  • Baird held 109,694 shares of CME Group worth $10.4M as of Q1 2015.
  • Baird sold 3,307 CME Group shares in Q1 2015, an estimated $306K.
  • CME Group made up 0.11% of Baird's portfolio in Q1 2015, its #204 holding.
  • Baird first reported a position in CME Group in Q2 2013 and has held it in 8 quarters since.
  • 588 funds tracked by Wall St. Rank held CME Group as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.